
Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue


Vol 16
No 3
May/Jun 2025
Rare Diseases and Educational Tools for Advanced Practitioners
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
May 15, 2025
A Pilot Program Implementing an Evidence-Based Walking Plan to Improve Cancer-Related Fatigue
Jennifer D. Bernt, DNP, FNP-C, AOCNP, Rita Million, PhD, RN, PHNA-BC, CNE, COI, Nicole S. Pham, MPH Et al.
May 15, 2025
Ductal Carcinoma In Situ Non Mass Enhancement on MRI 10 Years Before Mammographic Microcalcifications
Nancy W. Stead, MD, Andria P. Caton, RN, OCN, CHPN
May 15, 2025